Plain-English translation of NCT07176468 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Schizophrenia research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This study is testing a treatment called individualized intermittent theta-burst stimulation (iTBS)—a type of brain stimulation delivered with the help of MRI imaging to pinpoint the right brain location. Researchers want to see if this treatment, combined with regular antipsychotic medication, can help reduce schizophrenia symptoms more effectively than medication alone. Participants will receive daily brain stimulation sessions over 2 weeks in a real clinical setting.
Schizophrenia can be difficult to treat with medication alone, and many patients experience ongoing or returning symptoms. This trial aims to find out whether adding personalized brain stimulation to standard care could help more patients recover faster and stay healthier long-term.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll first have brain imaging scans and take cognitive and symptom tests to establish your baseline. Then, you'll receive daily brain stimulation sessions for 2 weeks while continuing your regular medication—no need to stop or change your current prescriptions. After the 2 weeks, you'll return for follow-up tests to see how your symptoms have changed and to check for any side effects.
AI-generated summary from trial data · Jul 20, 2026 · Not medical advice
China